|
Parameter
|
Value
|
|---|
|
Sex
|
|
Male
|
46(22.22%)
|
|
Female
|
161(77.78%)
|
|
Age
|
|
Average
|
53 ± 14.2
|
|
Range
|
14–87
|
|
HHT(F/M)
|
|
Negative
|
129(105/24)
|
|
Possible
|
29(23/6)
|
|
Definite
|
49(34/15)
|
|
Methods of examination
|
|
MSCT
|
103
|
|
CTA
|
104
|
|
Type of number (HHT/None)
|
|
Solitary
|
181 (59/122)
|
|
Unilateral multiple
|
5 (3/2)
|
|
Bilateral multiple (≤ 10)
|
13 (8/5)
|
|
Bilateral diffuse multiple (> 10)
|
8 (8/0)
|
|
Treatment of PAVMs
|
|
Follow-up observations
|
128 (61.8%)
|
|
Embolization
|
76 (36.7%)
|
|
Thoracoscope
|
4 (2%)
|
|
Embolization and thoracoscope
|
1 (0.5%)
|
- Data are presented as mean ± standard deviation or frequency (percentage). PAVMs pulmonary arteriovenous malformations, HHT hereditary haemorrhagic telangiectasia, M male, F female, MSCT multi-slice spiral computed tomography, CTA computed tomography angiography
